Acute myeloid leukemia arising from a donor derived premalignant hematopoietic clone: A possible mechanism for the origin of leukemia in donor cells

por Dickson, Mark A., Papadopoulos, Esperanza B., Hedvat, Cyrus V., Jhanwar, Suresh C., Brentjens, Renier J.
Publicado 2014

Kaposi Sarcoma of Childhood: Inborn or Acquired Immunodeficiency to Oncogenic HHV‐8

por Jackson, Carolyn C., Dickson, Mark A., Sadjadi, Mahan, Gessain, Antoine, Abel, Laurent, Jouanguy, Emmanuelle, Casanova, Jean‐Laurent
Publicado 2015

Preclinical and first‐in‐human phase I studies of KW‐2450, an oral tyrosine kinase inhibitor with insulin‐like growth factor receptor‐1/insulin receptor selectivity

por Schwartz, Gary K., Dickson, Mark A., LoRusso, Patricia M., Sausville, Edward A., Maekawa, Yoshimi, Watanabe, Yasuo, Kashima, Naomi, Nakashima, Daisuke, Akinaga, Shiro
Publicado 2016

ATRX is a regulator of therapy induced senescence in human cells

por Kovatcheva, Marta, Liao, Will, Klein, Mary E., Robine, Nicolas, Geiger, Heather, Crago, Aimee M., Dickson, Mark A., Tap, William D., Singer, Samuel, Koff, Andrew
Publicado 2017

SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with...

por Choy, Edwin, Ballman, Karla, Chen, James, Dickson, Mark A., Chugh, Rashmi, George, Suzanne, Okuno, Scott, Pollock, Raphael, Patel, Rajiv M., Hoering, Antje, Patel, Shreyaskumar
Publicado 2018

Corrigendum to “SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prio...

por Choy, Edwin, Ballman, Karla, Chen, James, Dickson, Mark A., Chugh, Rashmi, George, Suzanne, Okuno, Scott, Pollock, Raphael, Patel, Rajiv M., Hoering, Antje, Patel, Shreyaskumar
Publicado 2019

Randomized Phase 2 Clinical Trial of Olaratumab in Combination with Gemcitabine and Docetaxel in Advanced Soft Tissue Sarcomas

por Attia, Steven, Villalobos, Victor, Hindi, Nadia, Wagner, Andrew J., Chmielowski, Bartosz, Oakley, Gerard J., Peterson, Patrick M., Ceccarelli, Matteo, Jones, Robin L., Dickson, Mark A.
Publicado 2023

Proton radiotherapy for recurrent or metastatic sarcoma with palliative quad shot

por Lee, Anna, Kang, Jung J., Bernstein, Havah, Marqueen, Kathryn E., Neal, Brian, Kelly, Ciara M., Dickson, Mark A., Jillian Tsai, Chiaojung, Tap, William, Singer, Samuel, Alektiar, Kaled, Lee, Nancy Y.
Publicado 2021

PDLIM7 and CDH18 regulate the turnover of MDM2 during CDK4/6 inhibitor therapy-induced senescence

por Klein, Mary E., Dickson, Mark A., Antonescu, Cristina, Qin, Li-Xuan, Dooley, Scott J., Barlas, Afsar, Manova, Katia, Schwartz, Gary K., Crago, Aimee M., Singer, Samuel, Koff, Andrew, Tap, William D.
Publicado 2018

MDM2 turnover and expression of ATRX determine the choice between quiescence and senescence in response to CDK4 inhibition

por Kovatcheva, Marta, Liu, David D., Dickson, Mark A., Klein, Mary E., O'Connor, Rachael, Wilder, Fatima O., Socci, Nicholas D., Tap, William D., Schwartz, Gary K., Singer, Samuel, Crago, Aimee M., Koff, Andrew
Publicado 2015

TP53 mutations emerge with HDM2 inhibitor SAR405838 treatment in de-differentiated liposarcoma

por Jung, Joonil, Lee, Joon Sang, Dickson, Mark A., Schwartz, Gary K., Le Cesne, Axel, Varga, Andrea, Bahleda, Rastilav, Wagner, Andrew J., Choy, Edwin, de Jonge, Maja J., Light, Madelyn, Rowley, Steve, Macé, Sandrine, Watters, James
Publicado 2016

Early treatment-related neutropenia predicts response to palbociclib

por McAndrew, Nicholas P., Dickson, Mark A., Clark, Amy S., Troxel, Andrea B., O’Hara, Mark H., Colameco, Christopher, Gallager, Maryann, Gramlich, Kristi, Zafman, Kelly, Vaughn, David, Schwartz, Gary K., O’Dwyer, Peter J., DeMichele, Angela
Publicado 2020

A Phase I Study of Binimetinib (MEK162) Combined with Pexidartinib (PLX3397) in Patients with Advanced Gastrointestinal Stromal Tumor

por Rosenbaum, Evan, Kelly, Ciara, D'Angelo, Sandra P., Dickson, Mark A., Gounder, Mrinal, Keohan, Mary L., Movva, Sujana, Condy, Mercedes, Adamson, Travis, Mcfadyen, Chloe R., Antonescu, Christina R., Hwang, Sinchun, Singer, Sam, Qin, Li‐Xuan, Tap, William D., Chi, Ping
Publicado 2019

Phase II Trial of Gemcitabine and Docetaxel with Bevacizumab in Soft Tissue Sarcoma

por Dickson, Mark A., D'Adamo, David R., Keohan, Mary L., D'Angelo, Sandra P., Carvajal, Richard D., Gounder, Mrinal M., Maki, Robert G., Qin, Li-Xuan, Lefkowitz, Robert A., McKennon, Olivia R., Hirst, Catherine M., Schwartz, Gary K., Tap, William D.
Publicado 2015

nab-Sirolimus for Patients With Malignant Perivascular Epithelioid Cell Tumors

por Wagner, Andrew J., Ravi, Vinod, Riedel, Richard F., Ganjoo, Kristen, Van Tine, Brian A., Chugh, Rashmi, Cranmer, Lee, Gordon, Erlinda M., Hornick, Jason L., Du, Heng, Grigorian, Berta, Schmid, Anita N., Hou, Shihe, Harris, Katherine, Kwiatkowski, David J., Desai, Neil P., Dickson, Mark A.
Publicado 2021

Immune-related Adverse Events after Immune Checkpoint Blockade–based Therapy Are Associated with Improved Survival in Advanced Sarcomas

por Rosenbaum, Evan, Seier, Kenneth, Bradic, Martina, Kelly, Ciara, Movva, Sujana, Nacev, Benjamin A., Gounder, Mrinal M., Keohan, Mary L., Avutu, Viswatej, Chi, Ping, Thornton, Katherine A., Chan, Jason E., Dickson, Mark A., Donoghue, Mark T.A., Tap, William D., Qin, Li-Xuan, D'Angelo, Sandra P.
Publicado 2023

Long-term Follow-up and Patterns of Response, Progression, and Hyperprogression in Patients after PD-1 Blockade in Advanced Sarcoma

por Klemen, Nicholas D., Hwang, Sinchun, Bradic, Martina, Rosenbaum, Evan, Dickson, Mark A., Gounder, Mrinal M., Kelly, Ciara M., Keohan, Mary L., Movva, Sujana, Thornton, Katherine A., Chi, Ping, Nacev, Benjamin A., Chan, Jason E., Bartlett, Edmund K., Richards, Allison L., Singer, Samuel, Donoghue, Mark T.A., Tap, William D., D'Angelo, Sandra P.
Publicado 2022

Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center

por Rosenbaum, Evan, Antonescu, Cristina R, Smith, Shaleigh, Bradic, Martina, Kashani, Daniel, Richards, Allison L, Donoghue, Mark, Kelly, Ciara M, Nacev, Benjamin, Chan, Jason E, Chi, Ping, Dickson, Mark A, Keohan, Mary L, Gounder, Mrinal M, Movva, Sujana, Avutu, Viswatej, Thornton, Katherine, Zehir, Ahmet, Bowman, Anita S, Singer, Samuel, Tap, William, D’Angelo, Sandra
Publicado 2022

Phase Ib Trial of the Combination of Imatinib and Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumors

por Chi, Ping, Qin, Li-Xuan, Camacho, Niedzica, Kelly, Ciara M., D'Angelo, Sandra P., Dickson, Mark A., Gounder, Mrinal M., Keohan, Mary L., Movva, Sujana, Nacev, Benjamin A., Rosenbaum, Evan, Thornton, Katherine A., Crago, Aimee M., Francis, Jasmine H., Martindale, Moriah, Phelan, Haley T., Biniakewitz, Matthew D., Lee, Cindy J., Singer, Samuel, Hwang, Sinchun, Berger, Michael F., Chen, Yu, Antonescu, Cristina R., Tap, William D.
Publicado 2022

Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma

por D’Angelo, Sandra P., Richards, Allison L., Conley, Anthony P., Woo, Hyung Jun, Dickson, Mark A., Gounder, Mrinal, Kelly, Ciara, Keohan, Mary Louise, Movva, Sujana, Thornton, Katherine, Rosenbaum, Evan, Chi, Ping, Nacev, Benjamin, Chan, Jason E., Slotkin, Emily K., Kiesler, Hannah, Adamson, Travis, Ling, Lilan, Rao, Pavitra, Patel, Shreyaskumar, Livingston, Jonathan A., Singer, Samuel, Agaram, Narasimhan P., Antonescu, Cristina R., Koff, Andrew, Erinjeri, Joseph P., Hwang, Sinchun, Qin, Li-Xuan, Donoghue, Mark T. A., Tap, William D.
Publicado 2022